Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raymond Yan-Kit Kwong, M.D.

Co-Author

This page shows the publications co-authored by Raymond Kwong and Sharmila Dorbala.
Connection Strength

4.095
  1. A Policy Statement on Cardiovascular Test Substitution and Authorization: Principles of Patient-Centered Noninvasive Testing. J Am Coll Cardiol. 2021 Sep 28; 78(13):1385-1389.
    View in: PubMed
    Score: 0.247
  2. Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2021 Aug; 28(4):1761-1762.
    View in: PubMed
    Score: 0.245
  3. Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. J Nucl Cardiol. 2021 Aug; 28(4):1763-1767.
    View in: PubMed
    Score: 0.245
  4. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. Circ Cardiovasc Imaging. 2021 Jul; 14(7):e000030.
    View in: PubMed
    Score: 0.243
  5. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. Circ Cardiovasc Imaging. 2021 Jul; 14(7):e000029.
    View in: PubMed
    Score: 0.243
  6. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2021 Aug; 28(4):1769-1774.
    View in: PubMed
    Score: 0.243
  7. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. J Card Fail. 2021 Jul 01.
    View in: PubMed
    Score: 0.243
  8. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging. 2020 06; 13(6):1325-1336.
    View in: PubMed
    Score: 0.225
  9. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. J Nucl Cardiol. 2020 04; 27(2):659-673.
    View in: PubMed
    Score: 0.223
  10. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2019 12; 26(6):2065-2123.
    View in: PubMed
    Score: 0.218
  11. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. J Card Fail. 2019 Nov; 25(11):854-865.
    View in: PubMed
    Score: 0.214
  12. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. J Card Fail. 2019 Nov; 25(11):e1-e39.
    View in: PubMed
    Score: 0.214
  13. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1165-1173.
    View in: PubMed
    Score: 0.199
  14. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med. 2013 Oct; 54(10):1748-54.
    View in: PubMed
    Score: 0.141
  15. Multimodality imaging in the assessment of myocardial viability. Heart Fail Rev. 2011 Jul; 16(4):381-95.
    View in: PubMed
    Score: 0.122
  16. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009 Jul; 2(7):846-54.
    View in: PubMed
    Score: 0.106
  17. Multimodality imaging of an unusual case of cardiac paraganglioma. J Nucl Cardiol. 2009 Jul-Aug; 16(4):644-7.
    View in: PubMed
    Score: 0.104
  18. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. J Nucl Med. 2007 Mar; 48(3):349-58.
    View in: PubMed
    Score: 0.090
  19. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol. 2007 Feb 27; 49(8):855-62.
    View in: PubMed
    Score: 0.090
  20. Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint. JACC Cardiovasc Imaging. 2020 08; 13(8):1815-1833.
    View in: PubMed
    Score: 0.057
  21. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975.
    View in: PubMed
    Score: 0.053
  22. Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes. J Am Heart Assoc. 2019 01 08; 8(1):e007829.
    View in: PubMed
    Score: 0.051
  23. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2018 01; 11(1):e007030.
    View in: PubMed
    Score: 0.048
  24. Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. Am J Cardiol. 2014 Jul 15; 114(2):305-11.
    View in: PubMed
    Score: 0.037
  25. Yield of downstream tests after exercise treadmill testing: a prospective cohort study. J Am Coll Cardiol. 2014 Apr 08; 63(13):1264-1274.
    View in: PubMed
    Score: 0.036
  26. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014 Feb 04; 63(4):329-36.
    View in: PubMed
    Score: 0.036
  27. Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET. J Nucl Cardiol. 2010 Apr; 17(2):328-32.
    View in: PubMed
    Score: 0.028
  28. Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging. Eur J Nucl Med Mol Imaging. 2009 Oct; 36(10):1603-10.
    View in: PubMed
    Score: 0.026
  29. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation. 2008 Apr 01; 117(13):1693-700.
    View in: PubMed
    Score: 0.024
  30. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol. 2007 Nov-Dec; 14(6):799-809.
    View in: PubMed
    Score: 0.024
  31. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007 Mar 13; 49(10):1052-8.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.